How Gut Bacteria Could Transform Cancer Treatment

This was my discovery in terms of like how important acromancy is, is that in cancer patients receiving immunotherapy, I convened a conference with some colleagues in France in which the first ever announcement by a colleague of mine, Dr. Laurent Zitvogel at the Institut Gustave Roussy in Paris, is the biggest cancer research center in Europe, found that those patients who responded to immunotherapy, meaning their tumors actually shrank because their immune system got jacked up, had acromancy. And those people who did not respond it's a really bad thing when you don't respond to cancer therapy. They were missing Akkermansia. This one bacteria made the difference between response versus non-response. Jaw-droppingly, like, all the people in the audience that were there at that conference in 2017, like, literally, you could hear a pin drop, and then you could also hear all jaws hit the floor, like, wow, that is so profound. One bacteria. One bacteria. Okay.